Key points are not available for this paper at this time.
D espite recent advances in stroke prevention and acute stroke therapy, few treatments exist for reversal of fixed neurological deficits after stroke. Cellular therapy offers the possibility of improving neurological deficits months or even years after stroke. Animal studies provide evidence that such treatment may be effective. Many questions, however, remain unanswered regarding cellular therapy for stroke. In view of the significant differences between animal models and human stroke, some questions might be best addressed with clinical trials.
Lawrence R. Wechsler (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: